Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimensXiao Liu, Guangxun Gao, Yaya Gao et al.|Frontiers in Oncology|2022Cited by 10
Safety and efficacy of botulinum toxin type A made in China for treatment of post-stroke upper limb spasticity: a randomized double-blind controlled trialYingmai Yang, Weifeng Luo, Qi Liang et al.|Chin J Neurol|2018Cited by 1